Preparation for the treatment of diarrhoea

US20090175933A1Inactive Publication Date: 2009-07-09COLOCAPS
4 Cites 2 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
Publication Date
2009-07-09
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

A preparation for the treatment of diarrhoea comprising a bulking agent and an anti-diarrhoeal agent wherein the anti-diarrhoeal agent is provided in the form of an anti-motility agent.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS REFERENCE TO RELATED APPLICATION(S)

[0001] This application is a 35 U.S.C. § 371 National Phase Entry Application from pct / au2006 / 001469, filed Oct. 6, 2006, and designating the United States. This application also claims the benefit of Australian Patent Application No. 2005905533 filed Oct. 7, 2005, the disclosure of which is incorporated herein in its entirety by reference.BACKGROUND OF THE INVENTION

[0002] 1. Field of the Invention

[0003] The present invention relates to a preparation particularly suited to oral administration for the treatment of diarrhoea and other conditions associated with, or aggravated by, soft or liquid stool consistency.

[0004] 2. Background Art

[0005] Bulking laxatives such as fibre supplements are widely recommended as laxatives largely because they are free of any tendency to induce tolerance (increasing dose requirements). They cause a mild acceleration of colonic transit (i.e. they have only a mild laxative action) and tend to encourage bowel actions to ...

Examples

Embodiment Construction

[0039]The best mode for performing the invention will now be described. It should be noted that the following description does not limit the scope of the invention as described in the preceding disclosure.

[0040]The recommended daily dose of loperamide is 0.5 to 12 mg, depending on the individual's requirements. The recommended daily dose of Benefiber® (78% guar gum) is 4 to 8 g, which translates to a dose of guar gum of approximately 3 to 6 g, depending on the individual's requirements. Using midpoints of the ranges, recommended daily dosages for loperamide are about 4 mg and guar gum about 4 g. On this basis, a preparation in accordance with the present invention could comprises loperamide and guar gum an a 1:1000 ratio.

[0041]Where the preparation is provided in the form of a capsule, it is expected that each capsule could comprises between about 300 to 500 mg of guar gum and 0.3 to 0.5 mg of loperamide and it would be necessary to consume between up to 20 of the smaller capsules p...